Targeted blockade of TGF-β and IL-6/JAK2/STAT3 pathways inhibits lung cancer growth promoted by bone marrow-derived myofibroblasts
Abstract To investigate the role of TGF-β and IL-6 in myofibroblasts (MFs) — lung cancer cell interactions, lung cancer cells (Lewis and CTM-167 cell lines) were stimulated by IL-6, MF-conditioned medium (MF-CM) or MFs, with or without TGF-β signaling inhibitor — SB431542 and/or JAK2/STAT3 inhibitor...
Guardado en:
Autores principales: | Jindong Shi, Jingjing Feng, Juan Xie, Zhoufang Mei, Tianyun Shi, Shengmei Wang, Yong Du, Gong Yang, Yougen Wu, Xiaojiao Cheng, Shanqun Li, Liming Zhu, Chung S. Yang, Shuiping Tu, Zhijun Jie |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/834953b117d94032b1c80331230a11b1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
- JAK-STAT
-
Bridging Radiotherapy to Immunotherapy: The IFN–JAK–STAT Axis
por: Lewis Zhichang Shi, et al.
Publicado: (2021) -
The JAK/STAT signaling pathway: from bench to clinic
por: Xiaoyi Hu, et al.
Publicado: (2021) -
The molecular basis of JAK/STAT inhibition by SOCS1
por: Nicholas P. D. Liau, et al.
Publicado: (2018) -
Repeated intravenous administration of silica nanoparticles induces pulmonary inflammation and collagen accumulation via JAK2/STAT3 and TGF-β/Smad3 pathways in vivo
por: Yu Y, et al.
Publicado: (2019)